Thematic Review Series: Lysophospholipids and their Receptors: Autotaxin: Structure-function and signaling

Journal of Lipid Research

Volumn 55, Issue 6, 2014, Pages 1010-1018

  Perrakis, Anastassis ^a   Moolenaar, Wouter H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Ecto nucleotide pyrophosphatase phosphodiesterase; G protein coupled receptors; Inhibitors; Lysophosphatidic acid

Indexed keywords

AUTOTAXIN; INTEGRIN; ISOENZYME; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; PROTEOHEPARAN SULFATE; SOMATOMEDIN B; ALKYLGLYCEROPHOSPHOETHANOLAMINE PHOSPHODIESTERASE; LYSOPHOSPHOLIPID; PHOSPHODIESTERASE;

AMINO TERMINAL SEQUENCE; BIOAVAILABILITY; DRUG TARGETING; HYDROPHOBICITY; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TARGET CELL; ANIMAL; CHEMISTRY; GENETICS; HUMAN; METABOLISM; X RAY CRYSTALLOGRAPHY;

ANIMALS; CRYSTALLOGRAPHY, X-RAY; HUMANS; LYSOPHOSPHOLIPIDS; PHOSPHORIC DIESTER HYDROLASES; PROTEIN DOMAINS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84901688190     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R046391     Document Type: Review

References (84)

1. Bollen, M ., R. Gijsbers, H. Ceulemans, W. Stalmans, and C. Stefan. 2000. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit. Rev. Biochem. Mol. Biol. 35: 393-432.
2. Stefan, C., S. Jansen , and M. Bollen. 2005. NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem. Sci. 30: 542-550.
3. Zimmermann, H., M. Zebisch, and N. Strater. 2012. Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal. 8: 437-502.
4. Tokumura, A., E. Majima, Y. Kariya, K. Tominaga, K. Kogure, K. Yasuda, and K. Fukuzawa. 2002. Identifi cation of human pl asma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 277: 39436-39442.
5. Umezu-Goto, M., Y. Kishi, A. Taira, K. Hama, N. Do hmae, K. Takio, T. Yamori, G. B. Mills, K. Inoue, J. Aoki, et al. 2002. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158: 227-233.
6. van Meeteren, L. A., and W. H. Moolenaar. 2007. Regulation and biological activities of the autotaxin-LPA axis. Prog. Lipid Res. 46: 145-160.
7. Aoki, J., A. Inou e, and S. Okudaira. 2008. Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta. 1781: 513-518.
8. Bolen, A. L., A. P. Naren, S. Yarlagadda, S. Beranova-Giorgianni, L. Chen , D. Norman, D. L. Baker, M. M. Rowland, M. D. Best, T. Sano, et al. 2011. The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation. J. Lipid Res. 52: 958-97 0.
9. Bai, Z., L. Cai, E. Umemoto, A. Takeda, K. Tohya, Y. Komai, P. T. Veeraveedu, E. Hata, Y. Sugiura, A. Kubo, et al. 2013. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis. J. Immunol. 190: 2036-2048.
10. Kanda, H., R. Newton, R. Klein, Y. Morita, M. D. Gunn, and S. D. Rosen. 2008. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat. Immunol. 9: 415-423.
11. Umemoto, E., H. Hayasaka, Z. Bai, L. Cai, S. Yonekura, X. Peng, A. Takeda, K. Tohya, and M. Miyasaka. 2011. Novel regulators of lymphocyte traffi cking ac ross high endothelial venules. Crit. Rev. Immunol. 31: 147-169.
12. Choi, J. W., D. R. Herr, K. Noguchi, Y. C. Yung, C. W. Lee, T. Mutoh, M. E. Lin, S. T. Teo, K. E. Park, A. N. Mosley, et al. 2010. LPA receptors: subtypes and biological actions. Annu. Rev. Pharmacol. Toxicol. 50: 157-186.
13. Jongsma, M., E. Matas-Rico, A. Rzadkowski, K. Jalink, and W. H. Moolenaar. 2011. LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor. PLoS ONE. 6: e29260.
14. Oda, S. K., P. Strauch, Y. Fujiwara, A. Al Shami, T. Oravecz, G. Tigyi, R. Pelanda, and R. M. Torres. 2013. Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression. Cancer Immunol. Res. 1: 245-255.
15. Moolenaar, W. H., A. J. Houben, S. J. Lee, and L. A. van Meeteren. 2013. Autotaxin in embryonic development. Biochim. Biophys. Acta. 1831: 13-19.
16. Zhang Y.,Y.C. Chen,M.F. Krummel,S.D. Rosen, 2012. Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive T cells. J. Immunol. 189, 3914-3924.
17. Tager, A. M., P. LaCamera, B. S. Shea, G. S. Campanella, M. Selman , Z. Zhao, V. Polosukhin, J. Wain, B. A. Karimi-Shah, N. D. Kim, et al. 2008. The lysophosphatidic acid receptor LPA1 links pulmonary fi brosis to lung injury by mediating fi broblast recruitment and vascular leak. Nat. Me d. 14: 45-54.
18. Oikonomou, N., M. A. Mouratis, A. Tzouvelekis, E. Kaffe, C. Valavanis, G. Vilaras, A. Karameris, G. D. Prestwich, D. Bouros, and V. Aidinis. 2012. Pulmonary autota xin expression contributes to the pathogenesis of pulmonary fi brosis. Am. J. Respir. Cell Mol. Biol. 47: 566-574.
19. Inoue, M., M. H. Rashid, R. Fujita, J. J. Contos, J. Chun, and H. Ueda. 2004. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat. Med. 10: 712-718.
20. Smyth, S.S., Mueller, P., Yang, F., Brandon, J.A., and Morris, A.J. 2014. Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis. Arterioscler Thromb Vasc Biol.
21. Kremer, A. E., J. J. Martens, W. Kulik, F. Rueff, E. M. Kuiper, H. R. van Buuren, K. J. van Erpecum, J. Kondrackiene, J. Prieto, C. Rust, et al. 2010. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology. 139: 100 8-1018.
22. Houben, A. J., and W. H. Moolenaar. 2011. Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev. 30: 557-565.
23. Liu, S., M. Umezu-Goto, M. Murph, Y. Lu, W. Liu, F. Zhang, S. Yu, L. C. Stephens, X. Cui, G. Murrow, et al. 2009. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Can cer Cell. 15: 539-550.
24. Marshall, J. C., J. W. Collins, J. Nakayama, C. E. Horak, D. J. Liewehr, S. M. Steinberg, M. Albaugh, F. Vidal-Vanaclocha, D. Palmieri, M. Barbier, et al. 2012. Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer. J. Natl. Cancer Inst. 104: 1306-1319.
25. Peyruchaud, O., R. Leblanc, and M. David. 2013. Pleiotropic activity of lysophosphatidic acid in bone metastasis. Biochim. Biophys. Acta. 1831: 99-104.
26. Stracke, M. L., H. C. Krutzsch, E. J. Unsworth, A. Arestad, V. Cioce, E. Schiffmann, and L. A. Liotta. 1992. Identifi cation, purifi cation, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. Biol. Chem. 267: 2524-2529.
27. Jansen, S., C. Stefan, J. W. Creemers, E. Waelkens, A. Van Eynde, W. Stalmans, and M. Bollen. 2005. Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J. Cell Sci. 118: 3081-3089.
28. Koike, S., K. Keino-Masu, T. Ohto, and M. Masu. 2006. The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as a signal peptide. Genes Cells. 11: 133-142.
29. Jansen, S., M. Andries, K. Vekemans, H. Vanbilloen, A. Verbruggen, and M. Bollen. 2009. Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. Cancer Lett. 284: 216-221.
30. Dusaulcy, R., C. Rancoule, S. Gres, E. Wanecq, A. Colom, C. Guigne, L. A. van Meeteren, W. H. Moolenaar, P. Valet, and J. S. Saulnier-Blache. 20 11. Adipose-specifi c disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid. J. Lipid Res. 52: 1247-1255.
31. Chun, J., T. Hla, K. R. Lynch, S. Spiegel, and W. H. Moolenaar. 2010. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature. Pharmacol. Rev. 62: 579-587.
32. Yanagida, K., Y. Kurikawa, T. Shimizu, and S. Ishii. 2013. Current progress in non-Edg family LPA receptor research. Biochim. Biophys. Acta. 1831: 33-41.
33. Williams, J. R., A. L. Khandoga, P. Goyal, J. I. Fells, D. H. Perygin, W. Siess, A. L. Parrill, G. Tigyi, and Y. Fujiwara. 2009. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate rece ptor indicates role in human platelet activation. J. Biol. Chem. 284: 17304-17319.
34. Stortelers, C., R. Kerkhoven, and W. H. Moolenaar. 2008. Multiple actions of LPA on fi broblasts revealed by transcriptional profi ling. BMC Genomics. 9: 387.
35. Tokumura, A., Y. Nishioka, O. Yoshimoto, J. Shinomiya, and K. Fukuzawa. 1999. Substrate specifi city of lysophospholipase D which produces bioactive l ysophosphatidic acids in rat plasma. Biochim. Biophys. Acta. 1437: 235-245.
36. Ojala, P. J., M. Hermansson, M. Tolvanen, K. Polvinen, T. Hirvonen, U. Impola, M. Jauhiainen, P. Somerharju, and J. Parkkinen. 2006. Identifi cation of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine. Biochemistry. 45: 14021-14031.
37. Croset, M., N. Brossard, A. Polette, and M. Lagarde. 2000. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem. J. 345: 61-67.
38. Thumse r, A. E., J. E. Voysey, and D. C. Wilton. 1994. The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin. Biochem. J. 301: 801-806.
39. Guo, S., X. Shi, F. Yang, L. Chen, E. J. Meehan, C. Bian, and M. Huang. 2009. Structural basis of transport of lysophospholipids by human serum albumin. Biochem. J. 423: 23-30.
40. Inoue, A., N. Arima, J. Ishiguro, G. D. Prestwich, H. Arai, and J. Aoki. 2011. LPA-producing enzyme PA-PLAalpha regulates hair follicle development by modulating EGFR signalling. EMBO J. 30: 4248-4260.
41. Grisanti, L., A. Rezza, C. Clavel, R. Sennett, and M. Rendl. 2013. Enpp2/Autotaxin in dermal papilla precursors is dispensable for hair follicle morphogenesis. J. Invest. Dermatol. 133: 2332-2339.
42. van Dijk, M. C., F. Postma, H. Hilkmann, K. Jalink, W. J. van Blitterswijk, and W. H. Moolenaar. 1998. Exogenous phospholipase D generates lysophosphatidic acid and activates Ras, Rho and Ca2+ signaling pathways. Curr. Biol. 8: 386-392.
43. van Meeteren, L. A., F. Frederiks, B. N. Giepmans, M. F. Pedrosa, S. J. Billington, B. H. Jost, D. V. Tambourgi, and W. H. Moolenaar. 2004. Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine. J. Biol. Chem. 279: 10833-10836.
44. Lee, S., and K. R. Lynch. 2005. Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA). Biochem. J. 391: 317-323.
45. van der Bend, R. L., J. de Widt, E. J. van Corven, W. H. Moolenaar, and W. J. van Blitterswijk. 1992. Metabolic conver sion of the biologically active phospholipid, lysophosphatidic acid, in fi broblasts. Biochim. Biophys. Acta. 1125: 110-112.
46. Sciorra, V. A., and A. J. Morris. 2002. Roles for lipid phosphate phosphatases in regulation of cellular signaling. Biochim. Biophys. Acta. 1582: 45-51.
47. Ren, H., M. Panchatcharam, P. Mueller, D. Escalante-Alcalde, A. J. Morris, and S. S. Smyth. 2013. Lipid phosphate phosphatase (LPP3) and vascular development. Biochim. Biophys. Acta. 1831: 126-132.
48. Brindley, D. N., and C. Pilquil. 2009. Lipid phosphate phosphatases and signaling. J. Lipid Res. 50 ( Suppl ): S225-S230.
49. Tanaka, M., Y. Kishi, Y. Takanezawa, Y. Kakehi, J. Aoki, and H. Arai. 2004. Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma. FEBS Lett. 571: 197-204.
50. Salous, A. K., M. Panchatcharam, M. Sunkara, P. Mueller, A. Dong, Y. Wang, G. A. Graf, S. S. Smyth, and A. J. Morris. 2013. Mechanism of rapid elimination of lysophosphatidi c acid and related lipids from the circulation of mice. J. Lipid Res. 54: 2775-2784.
51. Hama, K., K. Bandoh, Y. Kakehi, J. Aoki, and H. Arai. 2002. Lysophosphatidic acid (LPA) receptor s are activated differentially by biological fl uids: possible role of LPA-binding proteins in activation of LPA receptors. FEBS Lett. 523: 187-192.
52. Goetzl, E. J., H. Lee, T. Azuma, T. P. Stossel, C. W. Turck, and J. S. Karliner. 2000. Gelsolin binding and cellular presentation of lysophosphatidic acid. J. Biol. Chem. 275: 14573-14578.
53. Osborn, T. M., C. Dahlgren, J. H. Hartwig, and T. P. Stossel. 2007. Modifi cations of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am. J. Physiol. Cell Physiol. 292: C1323-C1330.
54. Korekane, H., J. Y. Park, A. Matsumoto, K. Nakajima, S. Takamatsu, K. Ohtsubo, Y. Miyamoto, S. Hanashima, K. Kanekiyo, S. Kitazume, et al. 2013. Identifi cation of ectonucleotide pyrophosphat ase/phosphodiesterase 3 (ENPP3) as a regulator of N-acetylglucosaminyltransferase GnT-IX (GnT-Vb). J. Biol. Chem. 288: 27912-27926.
55. Giganti, A., M. Rodriguez, B. Fould, N. Moulharat, F. Coge, P. Ch omarat, J. P. Galizzi, P. Valet, J. S. Saulnier-Blache, J. A. Boutin, et al. 2008. Murine and human autotaxin alpha, beta, and gamma isoforms: gene organization, tissue distribution, and biochemical characterization. J. Biol. Chem. 283: 7776-7789.
56. Hashimoto, T., S. Okudaira, K. Igarashi, K. Hama, Y. Yatomi, and J. Aoki. 2012. Identifi cation and biochemical characterization of a novel autotaxin isoform, ATX -, with a four-amino acid deletion. J. Biochem. 151: 89-97.
57. Kawagoe, H., O. Soma, J. Goji, N. Nishimura, M. Narita, J. Inazawa, H. Nakamura, and K. Sano. 1995. Molecular cloning and chromo somal assignment of the human brain-type phosphodiesterase I/nucleotide pyrophosphatase gene (PDNP2). Genomics. 30: 380-384.
58. Fuss, B., H. Baba, T. Phan, V. K. Tuohy, and W. B. Macklin. 1997. Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. J. Neurosci. 17: 9095-9103.
59. Houben A.J.,X.M. Van Wijk,Van Meeteren L.A.,L. Van Zeijl,E.M. Van De Westerlo,J. Hausmann,A. Fish,A. Perrakis,T.H. Van Kuppevelt,W.H. Moolenaar, 2013. The polybasic insertion in autotaxin alpha confers specifi c binding to heparin and cell surface heparan sulfate proteoglycans. J. Biol. Chem., 288, 510-519.
60. Ferguson, C. G., C. S. Bigman, R. D. Richardson, L. A. van Meeteren, W. H. Moolenaar, and G. D. Prestwich. 2006. Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity. Org. Lett. 8: 2023-2026.
61. Saunders, L. P., W. Cao, W. C. Chang, R. A. Albright, D. T. Braddock, and E. M. De La Cruz. 2011. Kinetic analysis of autotaxin reveals substr ate-specifi c catalytic pathways and a mechanism for lysophosphatidic acid distribution. J. Biol. Chem. 286: 30130-30141.
62. Kreuger, J., D. Spillmann, J. P. Li, and U. Lindahl. 2006. Interactions between heparan sulfate and proteins: the concept of specifi city. J. Cell Biol. 174: 323-327.
63. Hausmann, J., S. Kamtekar, E. Christodoulou, J. E. Day, T. Wu, Z. Fulkerson, H. M. Albers, L. A. van Meeteren, A. J. Houben, L. van Zeijl, et al. 2011. Structural basis of substrate discrimination and integrin binding by autotaxin. Nat. Struct. Mol. Biol. 18: 198-204.
64. Nishimasu, H., S. Okudaira, K. Hama, E. Mihara, N. Dohmae, A. Inoue, R. Ishitani, J. Takagi, J. Aoki, and O. Nureki. 2011. Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. Nat. Struct. Mol. Biol. 1 8: 205-212.
65. Jansen, S., A. Perrakis, C. Ulens, C. Winkler, M. Andries, R. P. Joosten, M. Van Acker, F. P. Luyten, W. H. Moolenaar, and M. Bollen. 2012. Structure of NPP1, an ectonucleotide pyrophosphatase/phosphodiesterase involved in tissue calcifi cation. Structure. 20: 1948- 1959.
66. Kato, K., H. Nishimasu, S. Okudaira, E. Mihara, R. Ishitani, J. Takagi, J. Aoki, and O. Nureki. 2012. Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling. Proc. Natl. Acad. Sci. USA. 109: 16876-16881.
67. Zalatan, J. G., T. D. Fenn, A. T. Brunger, and D. Herschlag. 2006. Structural and functional comparisons of nucleotide pyrophosphatase/ phosphodiesterase and alkaline phosphatase: implications for mechanism and ev olution. Biochemistry. 45: 9788-9803.
68. Clair, T., J. Aoki, E. Koh, R. W. Bandle, S. W. Nam, M. M. Ptaszynska, G. B. Mills, E. Schiffmann, L. A. Liotta, and M. L. Stracke. 2003. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res. 63: 5446-5453.
69. Lambeau, G., and M. H. Gelb. 2008. Biochemistry and phy siology of mammalian secreted phospholipases A2. Annu. Rev. Biochem. 77: 495-520.
70. Scott, D. L., S. P. White, Z. Otwinowski, W. Yuan, M. H. Gelb, and P. B. Sigler. 1990. Interfacial catalysis: the mechanism of phospholipase A2. Science. 250: 1541-1546.
71. North, E. J., D. A. Osborne, P. K. Bridson, D. L. Baker, and A. L. Parrill. 2009. Autotaxin structure-activity relationsh ips revealed through lysophosphatidylcholine analogs. Bioorg. Med. Chem. 17: 3433-3442.
72. Moolenaar, W. H., and A. Perrakis. 2011. Insights into autotaxin: how to produce and present a lipid mediator. Nat. Rev. Mol. Cell Biol. 12: 674-679.
73. Fulkerson, Z., T. Wu, M. Sunkara, C. V. Kooi, A. J. Morris, and S. S. Smyth. 2011. Binding of autotaxin to integrins localizes lysophosphatidic acid producti on to platelets and mammalian cells. J. Biol. Chem. 286: 34654-34663.
74. Pamuklar, Z., L. Federico, S. Liu, M. Umezu-Goto, A. Dong, M. Panchatcharam, Z. Fulerson, E. Berdyshev, V. Nataraja n, X. Fang, et al. 2009. Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis. J. Biol. Chem. 284: 7385- 7394. [Erratum. 2009. J. Biol. Chem. 284: 21100.]
75. . Wu, T., C. V. Kooi, P. Shah, R. Charnigo, C. Huang, S. S. Smyth, and A. J. Morris. 2014. Integrin-mediated cell surface recruitment of autotaxin promotes persistent directional cell migration. FASEB J. 28: 861-870.
76. Barbayianni, E., V. Magrioti, P. Moutevelis-Minakakis, and G. Kokotos. 2013. Autotaxin inhibitors: a patent review. Expert Opin. Ther. Pat. 23: 1123-1132.
77. van Meeteren, L. A., P. Ruurs, E. Christodoulou, J. W. Goding, H. Takakusa, K. Kikuchi, A. Perrakis, T. Nagano, and W. H. Moolenaar. 2005. Inhibition of autotaxin by lysophosphatidic acid and sph ingosine 1-phosphate. J. Biol. Chem. 280: 21155-21161.
78. Albers, H. M., A. Dong, L. A. van Meeteren, D. A. Egan, M. Sunkara, E. W. van Tilburg, K. Schuurman, O. van Tellingen, A. J. Morri s, S. S. Smyth, et al. 2010. Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation. Proc. Natl. Acad. Sci. USA. 107: 7257-7262.
79. Kawaguchi, M., T. Okabe, S. Okudaira, H. Nishimasu, R. Ishitani, H. Kojima, O. Nureki, J. Aoki, and T. Nagano. 2013. Screening and X-ray crystal structure-based optimization of autotaxin (ENPP2) inhi bitors, using a newly developed fl uorescence probe. ACS Chem. Biol. 8: 1713-1721.
80. Gierse J.,A. Thorarensen,K. Beltey,E. Bradshaw-Pierce,L. Cortes-Burgos,T. Hall,A. Johnston,M. Murp hy,O. Nemirovskiy,S. Ogawa,et al.,2010. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of infl ammation. J. Pharmacol. Exp. Ther., 334,310-317.
81. Fells, J. I. , S. C. Lee, Y. Fujiwara, D. D. Norman, K. G. Lim, R. Tsukahara, J. Liu, R. Patil, D. D. Miller, R. J. Kirby, et al. 2013. Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophosp holipase D as an inhibitory surface. Mol. Pharmacol. 84: 415-424.
82. Groll, M., C. R. Berkers, H. L. Ploegh, and H. Ovaa. 2006. Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome. Structure. 14: 451-456.
83. Pettersen, E. F., T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, and T. E. Ferrin. 20 04. UCSF Chimera-A visualization system for exploratory research and analysis. J. Comput. Chem. 25: 1605-1612.
84. Joosten, R. P., K. Joosten, G. N. Murshudov, and A. Perrakis. 2012. PDB-REDO: constructive validation, more than just looking for errors. Acta Crystallogr. D Biol. Crystallogr. 68: 484-496.